CTA056 is anITK(IL-2-inducible T-cell kinase) inhibitor with anIC₅₀of 0.1 μM. CTA056 selectively targets malignant T cells and modulates oncomirs. CTA056 inducesapoptosisand is a potential therapeutic agent for the treatment of T-cell leukemia and lymphoma^[1].

554.68

C₃₅H₃₄N₆O

1265822-30-7

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.